Ctmx shares
WebApr 14, 2024 · Tang Capital Management LLC boosted its stake in shares of CytomX Therapeutics by 0.3% during the 4th quarter. Tang Capital Management LLC now owns … WebCTMX: Get the latest CytomX stock price and detailed information including CTMX news, historical charts and realtime prices. ... On Monday 03/27/2024 the closing price of the …
Ctmx shares
Did you know?
WebApr 14, 2024 · Shares of AdvisorShares Vice ETF ( NYSEARCA:VICE – Get Rating) rose 1.1% during mid-day trading on Thursday . The stock traded as high as $28.40 and last traded at $28.40. Approximately 845 ... WebMar 28, 2024 · Cash, cash equivalents, and investments of $194 million exclude the $35 million cash payment received under the Moderna agreement in Q1 2024. Price Action: CTMX shares are down 15.10% at $1.52 on...
WebCytomX Therapeutics, Inc. engages in the development of antibody therapeutics for the treatment of cancer based on its Probody therapeutic technology platform. Its pipeline … WebApr 14, 2024 · Cetera Investment Advisers bought a new position in shares of CytomX Therapeutics during the 4th quarter valued at about $32,000. Mackenzie Financial Corp purchased a new stake in CytomX...
WebApr 6, 2024 · Cytomx Therapeutics stock is currently +33.33% from its 52-week low of $1.17, and -48.34% from its 52-week high of $3.02. There are currently 66.23M CTMX shares outstanding. The market cap of CTMX is $103.32M. In the last 24 hours, 406,114 CTMX shares were traded. WebApr 13, 2024 · CytomX Therapeutics Inc. CTMX, +7.19% shares soared more than 50% in the extended session Thursday after the small biotech company announced a …
WebCTMX - Stock Price Chart CTMX [NASD] CytomX Therapeutics, Inc. Healthcare Biotechnology USA statements CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer.
WebMar 30, 2024 · CTMX stock opened at $1.54 on Thursday. The company has a market capitalization of $101.43 million, a PE ratio of -1.03 and a beta of 0.69. CytomX Therapeutics, Inc. has a 12 month low of $1.17... ear hook bluetooth wireless headphonesWebMar 10, 2024 · CytomX Therapeutics Inc. (NASDAQ: CTMX)’s stock price has decreased by -6.67 compared to its previous closing price of 2.10. Nevertheless, the company has seen a loss of -8.84% in its stock price over the last five trading days. Is It Worth Investing in CytomX Therapeutics Inc. (NASDAQ: CTMX) Righ css datalist styleWebApr 14, 2024 · The consensus estimate for Berry’s current full-year earnings is $0.81 per share. Capital One Financial also issued estimates for Berry’s Q3 2024 earnings at $0.21 EPS, Q4 2024 earnings at $0. ... css data typeWebGet the latest CytomX Therapeutics Inc (CTMX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … earhook earbudsWebCytomX Therapeutics, Inc. (CTMX) Stock Price, News, Quote & History - Yahoo Finance CytomX Therapeutics, Inc. (CTMX) NasdaqGS - NasdaqGS Real Time Price. Currency … ear hook earbuds wirelessWebMar 28, 2024 · The company’s shares closed last Monday at $1.79. According to TipRanks.com, Darout is a 4-star analyst with an average return of 7.4% and a 36.5% success rate. Darout covers the Healthcare... css datatable alternate row colorWebCytomX Therapeutics shares outstanding from 2014 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming … css data dictionary